Literature DB >> 30615523

Trends In Buprenorphine Prescribing By Physician Specialty.

Hefei Wen1, Tyrone F Borders2, Janet R Cummings3.   

Abstract

Office-based visits involving a buprenorphine prescription increased significantly among primary care and specialist physicians from 2006 to 2014. The growing involvement of nonpsychiatry physicians in buprenorphine prescribing has the potential to provide better access to care for people with opioid use disorders.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30615523     DOI： 10.1377/hlthaff.2018.05145

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN： 0278-2715            Impact factor:   6.301


  19 in total

1.  Geographic location of buprenorphine-waivered physicians and integration with health systems.

Authors:  Brendan Saloner; LeeKai Lin; Kosali Simon
Journal:  J Subst Abuse Treat       Date:  2020-05-12

2.  Financing Buprenorphine Treatment in Primary Care: A Microsimulation Model.

Authors:  Jonathan E Fried; Sanjay Basu; Russell S Phillips; Bruce E Landon
Journal:  Ann Fam Med       Date:  2020-11       Impact factor: 5.166

3.  U.S. alcohol treatment admissions after the Mental Health Parity and Addiction Equity Act: Do state parity laws and race/ethnicity make a difference?

Authors:  Nina Mulia; Camillia K Lui; Yu Ye; Meenakshi S Subbaraman; William C Kerr; Thomas K Greenfield
Journal:  J Subst Abuse Treat       Date:  2019-08-20

4.  Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?

Authors:  Taeho Greg Rhee; Robert A Rosenheck
Journal:  Addiction       Date:  2019-07-25       Impact factor: 6.526

5.  Primary Care Providers And Specialists Deliver Comparable Buprenorphine Treatment Quality.

Authors:  Alex K Gertner; Allison G Robertson; Byron J Powell; Hendree Jones; Pam Silberman; Marisa Elena Domino
Journal:  Health Aff (Millwood)       Date:  2020-08       Impact factor: 6.301

6.  Trends in Buprenorphine Treatment in the United States, 2009-2018.

Authors:  Mark Olfson; Victoria Shu Zhang; Michael Schoenbaum; Marissa King
Journal:  JAMA       Date:  2020-01-21       Impact factor: 56.272

7.  The impact of access to addiction specialist on attitudes, beliefs and hospital-based opioid use disorder related care: A survey of hospitalist physicians.

Authors:  Susan L Calcaterra; Ingrid A Binswanger; E Jennifer Edelman; Bryan K McNair; Sarah E Wakeman; Patrick G O'Connor
Journal:  Subst Abus       Date:  2020-04-08       Impact factor: 3.716

Review 8.  Identification and Management of Opioid Use Disorder in Primary Care: an Update.

Authors:  Joseph H Donroe; Elenore P Bhatraju; Judith I Tsui; E Jennifer Edelman
Journal:  Curr Psychiatry Rep       Date:  2020-04-13       Impact factor: 5.285

9.  It will end in tiers: A strategy to include "dabblers" in the buprenorphine workforce after the X-waiver.

Authors:  Brendan Saloner; Barbara Andraka Christou; Adam J Gordon; Bradley D Stein
Journal:  Subst Abus       Date:  2021-04-02       Impact factor: 3.716

10.  The Relationship Between Hepatitis C Virus Rates and Office-Based Buprenorphine Access in Ohio.

Authors:  Daniel L Brook; Angela T Hetrick; Shibani R Chettri; Christine A Schalkoff; Adams L Sibley; Kathryn E Lancaster; Vivian F Go; William C Miller; David M Kline
Journal:  Open Forum Infect Dis       Date:  2021-05-17       Impact factor: 3.835
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.